ROCHESTER, Minn. - Alzheimer's, it's a disease that impacts millions of Americans. On Oct. 1, Mayo Clinic hosted an 'After the Diagnosis' event to help the people diagnosed and their loved ones navigate this difficult path.

Mayo Clinic collaborated with Elder Network and other community organizations to give attendees resources and a better understanding of what this diagnosis means for people and their loved ones. Participants were able to hear from experts and ask questions.

Big topics from the Oct. 1 event included sharing ways to continue to live and strive after being diagnosed with dementia and new therapy and research that the Clinic is developing, making positive strides towards these diseases that currently do not have a cure.

Mayo Clinic Neurologist Dr. Jonathan Graff-Radford says, "the new therapies all target the amyloid protein so we call them anti-amyloid therapies and we now have two FDA approved therapies for Alzheimer's disease and they slow the disease down by 30%"

Associate in Neurology at Mayo Clinic, Angela Lunde says, "what we do a really good job of at Mayo Clinic is diagnosing and helping people understand what is wrong with them. That is an important first step to live a life of hope and well being."

These medication approvals are a big deal, we were told that it has been 20 years since Mayo Clinic's last Alzheimer's Disease medication was approved.

This was the first year that this event was held, and they are already planning for another seminar next year.